Skip to main content
Premium Trial:

Request an Annual Quote

Kathy Gibson, David Linthicum, Andrew Grimshaw

Premium

Kathy Gibson, worldwide head of research informatics at Pfizer, has joined Avaki’s newly created board of advisors. Other advisors include David Linthicum, former CTO of Mercator (now part of Ascential Software); Bob Metcalfe, founder of 3Com; Dave Henry, vice president at Temtec; and Eric Miles, CEO of Entopia. Philip Russom, director of research at Forrester Research, is the board’s facilitator, and Avaki founder Andrew Grimshaw is chairman.

Filed under

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.